Certified by Founder Lodge
Lilly Asia Ventures 礼来亚洲基金
China - Shanghai
INVESTOR
1 Disclosed Funding Rounds $200,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
N/A
| Company | Date | Round | Raised |
|---|---|---|---|
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Lynk Pharmaceuticals |
September, 22 ,2023 | Series C | |
 Akura Medical |
October, 04 ,2023 | Series B | $35,000,000 |
dezerv.
FalconX
Kristal.AI
Finary
Savart
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
